Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer prot
Author: ["Xian-Cheng Jiang","Shucun Qin","Chunping Qiao","Koichi Kawano","Min Lin","Anna Skold","Xiao Xiao","Alan R. Tall"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Increased secretion and levels of ApoB-containing lipoproteins (BLp) commonly occur in familial hyperlipidemia, obesity and diabetes. The plasma phospholipid-transfer protein (PLTP) is known to mediate transfer of phospholipids between BLp and HDL during their intravascular metabolism. To address a possible role of PLTP in dyslipidemia and atherogenesis, we bred mice deficient in the gene encoding PLTP (PLTP-deficient mice) using different hyperlipidemic mouse strains. In ApoB-transgenic and ApoE-deficient backgrounds, PLTP deficiency resulted in reduced production and levels of BLp and markedly decreased atherosclerosis. BLp secretion was diminished in hepatocytes from ApoB-transgenic PLTP-deficient mice, a defect that was corrected when PLTP was reintroduced in adenovirus. The studies reveal a major, unexpected role of PLTP in regulating the secretion of BLp and identify PLTP as a therapeutic target.
Cite this article
Jiang, XC., Qin, S., Qiao, C. et al. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7, 847–852 (2001). https://doi.org/10.1038/89977
